Sort
8,912 grants matching “sars cov 2”
Long COVID as a putative subtype of chronic fatigue syndrome
$370,568Richa Saxena · Massachusetts General Hospital · R01 · FY2022 · AI
Role of Uncharacterized Genes in High Pathogenic Human Coronavirus Infection
$370,377Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2015 · AI
Synthetic Scavenger Medical Countermeasures for Fentanyl
$370,293Michal Avital-Shmilovici · Sri International · R21 · FY2023 · DA
DNA Nanoparticle Vaccine for COVID-19
$370,098Mark Bathe · Massachusetts Institute Of Technology · R21 · FY2021 · EB
Sympathetic-Vascular Dysfunction in Obesity-Related Hypertension
$370,080Seth William Holwerda · University Of Kansas Medical Center · R01 · FY2025 · HL
SARS-CoV S Protein Receptor-binding Domain-based Vaccines
$370,061Shibo Jiang · New York Blood Center · R01 · FY2007 · AI
Infant Immunologic and Neurologic Development following Maternal Infection in Pregnancy during Recent Epidemics
$369,974Karin Nielsen · University Of California Los Angeles · R56 · FY2023 · AI
The role of SARS-CoV-2-induced senescence in the development of Alzheimer's Disease
$369,823Eleni Markoutsa · University Of South Florida · R01 · FY2025 · NS
A Predictive Modeling Framework to Dissect the Dynamic Immunometabolic Responses to Pathogenic infection and the Kinetic Reprogramming of Metabolism in Cancer Cell System
$369,554Rajib Saha · University Of Nebraska Lincoln · R35 · FY2021 · GM
Innovative Multiscale Modeling Techniques for Membrane-Bound Proteins
$369,500Yu-Ming Mindy Huang · Wayne State University · R35 · FY2025 · GM
Synthetically Accessible Virtual Inventory (SAVI)
$369,359Marc Nicklaus · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Covid-19 pandemic and changes in the prevalence, patterns, and trajectories of substance use and related health risk outcomes among young adults in WA State
$369,313Katarina Guttmannova · University Of Washington · R01 · FY2022 · DA
Covid-19 pandemic and changes in the prevalence, patterns, and trajectories of substance use and related health risk outcomes among young adults in WA State
$369,313Katarina Guttmannova · University Of Washington · R01 · FY2023 · DA
Xavier RCMI Renewal Application-Administrative Core
$369,149Guangdi Wang · Xavier University Of Louisiana · U54 · FY2021 · MD
COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in Southeastern Louisiana
$369,149Guangdi Wang · Xavier University Of Louisiana · U54 · FY2021 · MD
Sequelae of SARS-CoV-2 Infection in Alzheimer's Disease
$368,750Erin R Hascup · Southern Illinois University Sch Of Med · R01 · FY2020 · AG
Immunopathogenesis of SARS-CoV-2 infection
$368,653Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Investigating the link between pericyte dysfunction and loss of glucose homeostasis in COVID-19
$368,400Joana Almaca · University Of Miami School Of Medicine · R01 · FY2024 · DK
Complementopathies: biology, biomarkers, and targets
$368,356Robert A Brodsky · Johns Hopkins University · R56 · FY2022 · HL
Markov State Model approaches for folding, binding and design
$368,343Vincent Voelz · Temple Univ Of The Commonwealth · R01 · FY2023 · GM
Markov State Model approaches for folding, binding and design
$368,343Vincent Voelz · Temple Univ Of The Commonwealth · R01 · FY2024 · GM
Turning big data analysis infrastructure for HIV research
$368,281Anton Nekrutenko · Pennsylvania State University, The · R01 · FY2021 · AI
System Immunogenetics of SARS-CoV Infection
$367,995Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2013 · AI
System Immunogenetics of Influenza-Induced Innate and Adaptive Immunity in the L
$367,974Mark T Heise · Univ Of North Carolina Chapel Hill · U19 · FY2013 · AI
Aerosol Biology Small Animal Models
$367,626R Mark Buller · Washington University · U54 · FY2010 · AI